New Drugs Approved in 1st Quarter of 2016

Every quarter we strive to educate our customers with new medications that have been approved by the Federal Drug Administration. Among the newly approved drugs are:
Migraine sufferers have a new drug to look forward to trying. Approved in January of this year, Onzetra Xsail is a nasal powder for use in the acute treatment of migraine in adults. The maximum dose in a 24-hour period should not exceed two doses (44 mg) separated by at least two hours. Side effects can include, abnormal taste, nasal discomfort, excessive runny nose, and rhinitis (inflammation of the mucous membrane of the nose, nasal congestion and itching, and sneezing).
For adults and children with hemophilia A, Kovaltry is now available to control bleeding episodes as well as for use ahead of a surgical procedure. It an also be used routinely to reduce the frequency of bleeding episodes. The main side effect of Kovaltry is headache.
Those suffering with hemophilia B, Idelvion has been approved for children and adults and provides control for bleeding episodes both on-demand, and as an on-going preventative treatment. Both medications are to used intravenously. Primary side effects of Idelvion are headache, high fever, and itching.
A new HIV-1 treatment is now available for new patients 12 years and older. Taken orally once daily with a meal, Odefsey is used for those with no antiretroviral treatment history with HIV-1; or to replace a stable antiretroviral regimen in those who are virologically suppressed for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Odefsey. Common side effects include depression, insomnia, headache, and nausea.
Briviact has been approved for use in partial onset seizures related to epilepsy. Available in tablet, oral suspension and via intravenous administration, Briviact has been approved for patients 16 years and older.  Side effects include dizziness, fatigue, nausea and vomiting, and drowsiness.
If you have been diagnosed with any of these conditions, talk to your doctor about the right course of treatment for you. It’s also important to talk to your pharmacist to make sure any new medications you may be taking don’t negatively impact other medications you are currently taking.
 
Source: CenterWatch